| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/28/2001 | EP1086228A1 Recombinant production of toxoplasma sag1 antigen |
| 03/28/2001 | EP1086227A1 Novel maize orthologues of bacterial reca proteins |
| 03/28/2001 | EP1086226A1 Cyclin-dependent kinase inhibitors as plant growth regulators |
| 03/28/2001 | EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin |
| 03/28/2001 | EP1086224A1 B2 microglobulin fusion proteins and high affinity variants |
| 03/28/2001 | EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/28/2001 | EP1086222A2 Cell cycle regulation proteins |
| 03/28/2001 | EP1086221A2 Truncated apaf-1 and methods of use thereof |
| 03/28/2001 | EP1086219A2 Proteins regulating gene expression |
| 03/28/2001 | EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer |
| 03/28/2001 | EP1086217A2 Novel angiotensin receptor, production and use thereof |
| 03/28/2001 | EP1086216A2 Pseudo-cyclic oligonucleobases |
| 03/28/2001 | EP1086215A2 Preparation and use of superior vaccines |
| 03/28/2001 | EP1086214A1 Microneedle devices and methods of manufacture and use thereof |
| 03/28/2001 | EP1086213A2 Human genes differentially expressed in colon cancer |
| 03/28/2001 | EP1086212A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/28/2001 | EP1086211A2 Novel mannanases |
| 03/28/2001 | EP1086210A1 Novel mannanases |
| 03/28/2001 | EP1086209A2 Fy7 polymerase |
| 03/28/2001 | EP1086208A2 Galactosyltransferase from plants involved in galactomannan biosynthesis |
| 03/28/2001 | EP1086207A1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 03/28/2001 | EP1086205A1 Methods of monitoring disease states and therapies using gene expression profiles |
| 03/28/2001 | EP1086178A1 An anthraquinone and its derivatives |
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086136A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
| 03/28/2001 | EP1086133A1 A method for the removal/purification of serum albumins and means for use in the method |
| 03/28/2001 | EP1086132A1 Gene encoding organic anion transporter |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086128A2 Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof |
| 03/28/2001 | EP1086127A1 Novel compounds |
| 03/28/2001 | EP1086126A1 Cell-permeable peptide |
| 03/28/2001 | EP1086125A1 Respiratory nitrate reductase alpha subunit |
| 03/28/2001 | EP1086117A1 Cloning and identification of the motilin receptor |
| 03/28/2001 | EP1086116A1 Compositions and methods for the pulmonary delivery of nucleic acids |
| 03/28/2001 | EP1085904A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 03/28/2001 | EP1085898A1 Parasite antigens |
| 03/28/2001 | EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 03/28/2001 | EP1085857A2 Cationic amphiphile micellar complexes |
| 03/28/2001 | EP1085811A1 Broad specificity dna damage endonuclease |
| 03/28/2001 | EP0863999B1 Method of detecting telomerase activity |
| 03/28/2001 | EP0759087B1 Compositions and methods for targeting gene delivery vehicles |
| 03/28/2001 | EP0495096B1 Plant fatty acid synthases |
| 03/28/2001 | EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
| 03/28/2001 | CN1289424A Methods and apparatus for preforming sequence homology detection |
| 03/28/2001 | CN1289374A Detection of wheat and barley fungal phthogens using the polymerase chain reaction |
| 03/28/2001 | CN1289373A Inhibition of DNA modulation caused by mutated p53 |
| 03/28/2001 | CN1289372A Gene expression methods for screening compounds |
| 03/28/2001 | CN1289371A Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications |
| 03/28/2001 | CN1289370A Method for transferring gene into germ cell |
| 03/28/2001 | CN1289369A Riboflavin biosynthesis genes from plants and uses thereof |
| 03/28/2001 | CN1289368A Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium |
| 03/28/2001 | CN1289367A Plant alkaline and neutral invertases |
| 03/28/2001 | CN1289366A Human TSC403 gene and human INGIL gene |
| 03/28/2001 | CN1289339A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 03/28/2001 | CN1289253A Treating atopic dermatitis with lgE antagonists |
| 03/28/2001 | CN1288952A Procaryon secreted expression carrier and its use |
| 03/28/2001 | CN1288951A Two-component signal system gene and the protein encoded by it |
| 03/28/2001 | CN1288950A Preparation and application of monocloning antibody based on DNA immunity |
| 03/28/2001 | CN1288897A Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment |
| 03/28/2001 | CN1288754A Gene treatment to raise feed efficiency and promote growth of farm animal |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/28/2001 | CN1063795C Method for production of glucagon |
| 03/28/2001 | CN1063793C Two carriers based on pBV220 carrier |
| 03/28/2001 | CN1063792C Hamanized antibodies and uses thereof |
| 03/28/2001 | CN1063791C Reyulatory sequence of alpha-fetoprotein gene expression and its use |
| 03/28/2001 | CN1063790C Method for RNA circulation reverse transcription reaction |
| 03/28/2001 | CN1063757C Gene structure with calcitonin gene related peptide (CGRP) and preparing method thereof |
| 03/28/2001 | CN1063756C Double antigen containing hepatitis B virus and hepatitis C virus core antigen simultaneously |
| 03/27/2001 | US6208941 Method and apparatus for analysis of chromatographic migration patterns |
| 03/27/2001 | US6207883 DNA sequences coding for a protein conferring male sterility |
| 03/27/2001 | US6207882 Disease resistant transgenic plants comprising a tomato aspermy virus 2b gene |
| 03/27/2001 | US6207881 Control of fruit ripening through genetic control of ACC synthase synthesis |
| 03/27/2001 | US6207880 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 03/27/2001 | US6207879 Maize RS81 promoter and methods for use thereof |
| 03/27/2001 | US6207878 Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations |
| 03/27/2001 | US6207877 Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding |
| 03/27/2001 | US6207876 Adenosine deaminase deficient transgenic mice and methods for the use thereof |
| 03/27/2001 | US6207818 Amplification and detection of shigella spp. and enteroinvasive strains of Escherichia coli |
| 03/27/2001 | US6207817 Fish insulin-like growth factor II promoter |
| 03/27/2001 | US6207816 High affinity oligonucleotide ligands to growth factors |
| 03/27/2001 | US6207815 Dna coding for chimeric heavy chain or antigen binding fragment produced by specific cell lines; combines with high molecular weight, tumor-associated sialylated glycoprotein antigen light chain; diagnosis; imaging |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207813 BMP-6 proteins |
| 03/27/2001 | US6207812 Chondrosarcoma associated genes |
| 03/27/2001 | US6207806 IGF-I purification process |
| 03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
| 03/27/2001 | US6207804 Genetically engineered antibody analogues and fusion proteins thereof |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207797 Deactivation of reactive species present on surface of copolymer by antiradical chemical treatment, electrochemical treatment to modify the degree of oxidation, and/or rinsing operations using a surfactant |
| 03/27/2001 | US6207648 Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207645 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207457 Targeted nucleotide sequence delivery and integration system |
| 03/27/2001 | US6207456 Nucleic acid delivery vehicle |